Fendx Technologies, Inc. · CSE:FNDX
Fendx Technologies — Investor Presentation (December 2023)
20 slides from Fendx Technologies's investor presentation, December 2023
Slide 1: Making Lives Safer Through Nanotechnology
Making Lives Safer Through NANOTECHNOLOGY P R E V E N T I N G T H E S P R E A D O F PAT H O G E N S CSE: FNDX | OTCQB: FDXTF | FSE: E8D DECEMBER 2023
Slide 2: Forward-Looking Statement
Forward-Looking Statement This presentation contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; expectations regarding industry trends, including with respect to the antimicrobial surface and coating
Slide 3: Fendx Is a Nanotechnology Company Focused On
FENDX IS A NANOTECHNOLOGY COMPANY FOCUSED ON: Using its nanotechnology to develop nano-coated film and spray-on film products to reduce the spread of pathogens on surfaces CSE: FNDX | OTCQB: FDXTF | FSE:E8D DECEMBER 2023 / 3
Slide 4: Film and Spray-on Film Products in Development Exhibit Unique Repelling Properties
Film and Spray-on Film Products in Development Exhibit Unique Repelling Properties to Prevent Adhesion of Bacteria and Viruses Film Spray Untreated Treated Surface* Surface* >99% reduction in adhesion >98% reduction in of a COVID-19 like virus1, adhesion of a COVID-19 MRSA, E. coli and B. like virus
Slide 5: Effective Pathogen Control Requires Innovative Solutions
Effective Pathogen Control Requires Innovative Solutions The Problem • Healthcare-acquired infections are one of the top 10 frequent causes of death globally 1 • > 99,000 of deaths annually in U.S.2 • $28.4 billion in direct medical costs annually in the U.S.2 • Global health protection agencies pro
Slide 6: Surfaces Can Spread Pathogens
Surfaces Can Spread Pathogens Pathogens Exist in Critical and Everyday Environments on High-touch Surfaces HEALTHCARE TRANSPORTATION SPORTS & SCHOOLS OFFICES ENVIRONMENTS ENTERTAINMENT DOORKNOBS, HANDRAILS & MORE ELEVATOR PANELS & BUTTONS COUNTERTOPS & TABLES IV POLES LIGHT SWITCHES TROLLEYS & EQUIP
Slide 7: How Our Protective Nano-Coatings Work
How Our Protective Coated with Nanotechnology Nano-Coatings Work A Solution to Protect High Touch Surfaces • When a contaminated hand touches a nano-coated surface, the contamination Uncoated tends to stay on the hand and not transfer to the surface • If bacteria or viruses land on nano- coated surf
Slide 8: REPELWRAP Film
REPELWRAP™ Film Lead Product in Development • Expected to be easy to apply and provide immediate and 24/7 protection for extended periods of time • Intend to develop a nano-coated film with an adhesive backing for easy application on flat surfaces, handrails etc. • Effective repelling rates: • >99%
Slide 9: REPELWRAP Film Composition and Patent Portfolio
REPELWRAP™ Film Film Composition • Deposition of nanoparticles on plastic film substrate, followed by deposition of fluoropolymers and then thermally shrunk • Creates an inert surface with unique repelling properties that prevents the adhesion of bacteria, viruses, blood and other liquids Schematic
Slide 10: REPELWRAP Film Manufacturing Pilot Run
REPELWRAP™ Film Confirmed Automation from Manufacturing Pilot Run of Nano-Coated Film Formula • Production time streamlined • Achieved the expected repelling properties • In the process of optimizing formulation and manufacturing process • Anticipate introduction of a commercial product in 2H2024 *
Slide 11: REPELWRAP Film Competitive Landscape
REPELWRAP™ Film Competitive Landscape Metal- REPELWRAP™ Liquid Containing** and Film* Disinfectants Photo-Activated Films Surface repels bacteria, viruses, +++ - - blood and liquids Instantly effective +++ +++ + 24/7 protection +++ - +++ Does not promote bacterial resistance +++ + + * Based on McMas
Slide 12: Spray-On Film Formulation In Development
Spray-On Film Formulation In Development Spray-on film both repels and kills: • >98% reduction in adhesion of MRSA and Covid-19 like virus1 • Spray-on-film may be easier to apply to many surfaces and expands potential market applications • 99.98% reduction in biofilm formation for both MRSA and P. a
Slide 13: Growth Strategy
Growth Strategy • Additional uses of nanotechnology, including medical devices i.e., coating catheters • Explore partnerships to expand pipeline and portfolio • Assess licensing/acquisition of products complementary products in infection control • Expand into the U.S. and other markets CSE: FNDX | O
Slide 14: Catheter Development Program
Catheter Development Program Key findings from early-stage research of Failure of long-term indwelling catheters is coated catheters using our nanotechnology1: commonly caused by blood clots and/or bacterial biofilm formation • 98.5% reduction in adhesion of MRSA and P. aeruginosa 2027 • 95% redu
Slide 15: Antimicrobial & Antiviral Nano-Coating Market Offers a Significant Opportunity
Antimicrobial & Antiviral Nano-Coating Market Offers a Significant Opportunity Global market estimated to reach $1.3 billion in 20261. $1,400 $1.3B $1,200 $1,000 $800 $600 $400 $200 $0 2022 2023 2024 2025 2026 Sources: 1. Future Markets Technology Report, Advanced Microbial Coatings, 2021 CSE: FNDX
Slide 16: Partner with Manufacturers and Distributors
Partner with Manufacturers and Distributors Manufacturers Sales Distributors Establish partnerships to manufacture Secure partnerships to sell REPELWRAPTM REPELWRAPTM film and other products film in Canada, U.S. and other global for distribution in Canada, U.S. and markets other global markets Goal
Slide 17: Proven Team Management
Proven Team Management Dr. Carolyn Myers MBA, PhD Andrea Mulder BPHE, MBA Rose Zanic CPA, CA President, CEO & Director COO CFO & Corporate Secretary • Principal of BioEnsemble LLC, assisting • Over 25 years of pharma/biotech • Over 25 years of capital markets and start-ups and small pharma companies
Slide 18: Board of Directors
Board of Directors Dr. Carolyn Myers MBA, PhD Stephen Randall CPA, CGA Pierre Soulard B.C.L., LLB, LLM President, CEO & Director Independent Board Member Independent Board Member & Audit Committee Chair • Principal of BioEnsemble LLC, • Chief Legal Officer of CoinSmart assisting start-ups and small
Slide 19: Share Structure
Share Structure CSE: FNDX / AS OF NOVEMBER 30, 2023 Common Stock1 52,991,606 Stock Options 2,741,667 • Efficient capital structure Warrants 15,905,807 • Over 54% of common shares subject to escrow/pooling Bonus Shares2 4,150,000 restrictions Fully-Diluted 75,789,080 1 29,055,800 shares subject to es
Slide 20: Thank You!
Thank You! Reach out to us with any questions. investor@fendxtech.com / fendxtech.com CSE: FNDX | OTCQB: FDXTF | FSE:E8D DECEMBER 2023 / 20
Fendx Technologies — Investor Presentation (December 2023) on 6ix